pyrimidine-3-yl)acetamide (18F-DPA-714) is a radioligand for the 18-kDa translocator protein.
INTRODUCTION
Increased activation of microglial cells can be detected at very early stages following brain injury (1) . Although microglial activation has been linked to normal ageing, it is primarily associated with neuroinflammation caused by a variety of diseases such as multiple sclerosis, multiple system atrophy, and Alzheimer's Disease (AD) (2) . An increase in activated microglia results in higher expression of the 18-kD translocator protein (TSPO) (3) . Consequently, TSPO has been a target of interest for developing diagnostic positron emission tomography (PET) tracers.
18F- (N,N-diethyl-2-(2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethylpyrazolo[1,5-α]pyrimidine-3-yl)acetamide) is a PET ligand with high specificity for TSPO. Early studies showed that 18F-DPA-714 had better bioavailability(4), lower non-specific binding and higher binding potential than 11C-DPA-713 (5) . It is considered to be superior over 11C-PK11195 (6) (7) (8) (9) in terms of specificity and, hence, it could be a potential tracer for assessing the early stages of AD.
In a recent study (10) , quantification of 18F-DPA-714 binding was performed using nonlinear regression of regional time activity curves and a metabolite corrected plasma input function. 18F-DPA-714 kinetics were described best by a reversible two tissue compartment model with blood volume fraction parameter. In the same study, data from AD patients and healthy subjects were compared with each other, but 18F-DPA-714 did not allow for identifying individual AD patients. This comparison, however, was based on predefined regions of interest of various brain structures and possible differences in parts of these regions may have gone unnoticed due to dilution with non-different parts in the same regions.
The main purpose of this study was to identify the most suitable method for parametric quantification of 18F-DPA-714 binding. A secondary aim was to assess whether these parametric images can be used for a comparison of normal healthy subjects and AD patients at the voxel level.
MATERIALS AND METHODS

Subjects
The material of this study was the same as that of a previous study in which the optimal tracer kinetic model for 18 F-DPA-714 was identified (10) . In short, nine probable AD patients (age 73.7±8.4 years, mini-mental state examination (MMSE) 24.6±2.8, disease duration 2.5±1.7 years) and six healthy subjects (age 64.5±5.5, MMSE 28.8±0.8) were included. AD patients were only considered when they fulfilled National Institute of Neurological and Communicative Disorders and Stroke -Alzheimer's Disease and Related Disorders Association and Diagnostic and Statistical Manual of Mental Disorders, 4th Edition criteria. The Finnish Medicines Agency and the Netherlands Central Committee on Research Involving Human Subjects, the local Ethics Committees of the Southwest Hospital District of Finland and the VU University Medical Center approved the study. It was conducted in line with the Helsinki Declaration and was registered at www.ClinicalTrials.gov (NCT01009359). All subjects gave written informed consent for participation in the study.
Scanning protocol
Structural T1 weighted magnetic resonance images (MRI) were acquired for all subjects on a Philips Intera 1.5 Tesla scanner (Philips Medical Systems, Best, The Netherlands). Dynamic PET emission scans (90 minutes) were acquired using an ECAT EXACT HR+ scanner (CTI/Siemens, Knoxville, TN, USA) following administration of 250 ± 10 MBq 18F-DPA-714. Prior to this emission scan a transmission scan for attenuation correction purposes was acquired. Dynamic scans were reconstructed into a single dynamic dataset of 33 frames (6x5, 3x10, 3x20, 4x60, 6x180, 11x360 s) using 2D filtered backprojection with Fourier rebinning, a Hanning filter (cutoff 0.5), a matrix size of 256x256x47, a field of view of 15.7 cm and a final voxel size of 1.17x1.17x3.27 mm 3 . All appropriate corrections for dead time, attenuation, scatter and randoms were applied during reconstruction. In addition, the metabolite corrected parent plasma input function was measured using an automated arterial blood sampling system (ABSS, Allogg, Sweden), together with manual blood samples collected at 6 different time points (5, 10, 20, 30, 45 , and 60 min post injection). These manual samples were used for estimation of plasma to whole blood concentration ratios, and for measurement of labelled metabolite fractions.
Data analysis
For each subject, MRI data were co-registered to the summed 18F-DPA-714 image (0.3 to 24 minutes) using VINCI software (11) . Regional time activity curves were extracted using PVElab software (12) , in which the Hammers template(13) was projected onto the co-registered MRI scan and subsequently applied to the dynamic 18F-DPA-714 scan. Regional kinetic parameters (binding potential (BP ND ), distribution volume (V T ), and the rate constant from blood to tissue (K 1 ) were obtained using non-linear regression (NLR) and the reversible two-tissue compartment model with blood volume fraction parameter as described previously (10) . Results from this previous study (10) suggested that cerebellum might be used as a reference region in order to assess distribution volume ratios (DVRs). DVR is the ratio of regional to reference V T . Cerebellum was also used as reference region to obtain BP ND using the simplified reference tissue model (SRTM) (14) . Kinetic parameters were used to assess the performance of various parametric methods.
Parametric methods. Parametric V T images were generated using plasma input based Logan graphical(15) and spectral(16) analyses. Regional V T values were extracted from these parametric images using the Hammers template (13) . Values obtained for all regions from the Hammers template were then compared with corresponding (same region) V T values obtained using NLR. As for NLR, cerebellum was used as reference tissue to generate parametric BP ND images. Six types of reference input based linearization techniques, i.e. five versions of the multilinear reference tissue models (MRTM0, MRTM1, MRTM2, MRTM3, MRTM4) (17) (18) (19) and reference Logan(20) (RLogan), were used to generate parametric BP ND (DVR-1 using reference Logan) images.
Finally, again using cerebellum as reference region, BP ND images were generated using two basis function implementations of SRTM, i.e. receptor parametric mapping (RPM)(21) without and with fixing the efflux rate constant of the reference region. In the latter approach (SRTM2), the efflux rate constant of the reference region is first estimated for each voxel using RPM and subsequently fixed to its median value in a second run, as described by Wu and Carson(22) . Regional BP ND values from the parametric images were compared with NLR derived DVR-1 and SRTM BP ND , respectively, to evaluate the accuracy of each of the implementations. Table 1 lists, where appropriate, time intervals and range of basis functions for all parametric implementations investigated. These settings were derived empirically, e.g. by using the linear part of the Logan plot (15) (16) (17) (18) (19) (20) or by calibrating the range of basis functions based on regional NLR microparameter values (21) . In case of Logan and RLogan, different start and end times were evaluated and compared with corresponding NLR estimates to assess the optimal time points. Similarly, different ranges and numbers of basis functions were explored and regional values were compared with corresponding NLR values to identify optimal settings for each implementation. Parametric images were obtained using software developed in-house (PPET) (23) .
Statistical Parametric Mapping(SPM).
In a previous study (10) , no significant differences in 18F-DPA-714 binding at a regional level were found between AD patients and healthy subjects. Parametric images make it possible to investigate differences in binding at a voxel level. Therefore, the most appropriate parametric images, together with SPM8 (http://www.fil.ion.ucl.ac.uk/spm/software/spm8/), were used to perform a preliminary analysis for assessing whether differences in 18F-DPA-714 binding between subject groups could be detected. The main aim of this analysis was to assess whether these parametric methods can be used for a voxel wise analysis. Clinical interpretation is beyond the scope of the present study and will require larger patient samples that are homogeneous with respect to genotype. Each subject's T1 weighted MRI scan was normalised to Montreal Neurological Institute space as defined by the SPM template. Next, the resulting normalisation parameters were applied to individual V T and BP ND images. SPM analyses were performed using the two-sample t-test (p<0.05, cluster size >25). In addition, SPM analyses were used to assess correlation of parametric V T and BP ND with age, MMSE and disease duration. Parametric images were also obtained from the datasets that were corrected for partial volume effect (PVE) using iterative deconvolution (24) , (8) . Additional SPM analyses were performed using these PVE corrected parametric images. Fig 1 shows examples of various parametric images generated using both plasma input and reference tissue based parametric methods. In addition, R 1 (relative delivery) images obtained using RPM and SRTM2, and V T images obtained using SA and Logan plot analyses are shown. Interestingly, none of the MRTM implementations provided parametric images with acceptable visual image quality.
RESULTS
Parametric images
Regional parametric V T values derived using plasma input Logan and SA methods correlated well (r 2 = 0.99 and r 2 = 0.99, respectively) with those obtained using plasma input NLR (Fig 2) . BP ND derived from A) RPM, B) SRTM2, C) RLogan plotted against those obtained from reference tissue NLR (BP ND ) are shown in Fig 3. BP ND data generated using RPM (r 2 = 0.84), SRTM2 (r 2 = 0.83) and RLogan (r 2 = 0.88) correlated well with NLR estimates based on SRTM. Table 2 provides correlations, slopes and intercepts obtained for all the parametric implementations against their corresponding NLR counterparts. Regional BP ND derived from RLogan (r 2 = 0.95), RPM (r 2 = 0.80) and SRTM2 (r 2 = 0.80) also correlated well with BP ND (calculated from DVR-1) obtained from plasma input NLR.
Statistical parametric mapping
Based on the good quantitative results of V T obtained using Logan and SA, and those of BP ND obtained using SRTM2 and RLogan, parametric images of the methods were used for further analysis. Using SPM, significant differences were seen between subject groups for BP ND images in parts of the frontal and medial temporal lobes ( Supplemental Fig 1) . R1 images also showed significant differences between the subject groups but with smaller clusters. No clusters were found that showed correlation with age, MMSE or disease duration (within the AD patient group) in any of the parametric images. Supplementary Fig 2 illustrates the impact of PVE correction on observed differences.
DISCUSSION
Following the previous study in which the optimal tracer kinetic model was identified (10) , the focus of the present study was to assess various parametric methods for quantitative analyses of 18F-DPA-714 PET studies. In case of plasma input, both Logan and SA provided V T estimates that correlated well with those obtained from full kinetic analyses (NLR). Similarly, both RLogan and SRTM2, using cerebellum as reference region, provided reliable estimates of BP ND compared to those seen with SRTM. Finally, applying SPM to the parametric images mentioned above provided small, but significant differences between normal controls and AD patients were observed in parts of frontal and medial temporal lobes, which went unnoticed in the previous analysis using predefined regions of interest. However, the observed small differences seems to decrease further after PVC. Therefore, care should be taken in interpreting the observed differences, as this will require larger sample sizes that are homogeneous with respect to genotype. Table 2 illustrate that parametric images generated by the Logan plot slightly underestimate V T compared with full kinetic analysis. This underestimation has been described previously and was attributed to noise induced negative bias (25) . In addition, the Logan linearization in our implementation does not take into account the fractional blood volume this may also result in a negative bias. Unlike Logan, SA incorporates a blood volume fraction parameter, which is likely to explain the better agreement with V T estimates derived from full kinetic analysis (slope closer to 1 in Table 2 ). Outliers in Fig 2 and 3 are neither from the same subject nor from the same region. These outliers results from regions that were either small or had a lower activity concentration, resulting in higher noise levels.
Fig 2 and
For the reference tissue methods, both RLogan and SRTM2 provided good correlations (0.88 and 0.83, respectively) of BP ND with corresponding NLR values. An important advantage of SRTM2 is that it also provides parametric images of relative delivery (R 1 ). In principle, further improvement in precision could be obtained using SRTM2, a refinement of RPM, in which the rate of clearance from the reference region is fixed to the median value obtained from a first run using RPM (22) . Hence there was a better slope with SRTM2 when compared to RPM. Subsequently, BP ND derived from SRTM2 was used for SPM analysis.
TSPO is widely expressed in the brain and, therefore, it is difficult, if not impossible, to define an ideal reference tissue devoid of binding sites. In the present study, cerebellum was used as reference tissue. As discussed previously 10 , there was no clear indication that cerebellum was not suitable as reference region. Indeed, many studies(26-27) using TSPO ligands have used cerebellum as reference region. Nevertheless, further studies are required to validate this approach. An alternative way of obtaining a suitable reference region would be the use of methods such as supervised cluster analysis (28) . For the present study this approach was not possible, as it requires larger datasets to predefine the necessary kinetic classes.
It should be noted that the significant differences between subject groups in both parametric BP ND and V T images were not seen in the previous study using predefined regions of interest (10) . This discrepancy may be explained by the fact that the disease related signal is small and comprises only part of those predefined regions of interest. Therefore, the regional comparison was diluted with many voxels in which there was no difference between AD patients and healthy controls. Indeed, SPM analysis only revealed small clusters that were, however, located in similar areas as those observed in previous (R)-[ Atrophy in AD subjects may have had an effect on the observed differences in the analysis mentioned above. As atrophy may increase PVE, there is a possibility that differences are underestimated when using datasets that are not corrected for PVE. Therefore, parametric images were also obtained using PVE corrected datasets, with PVC based on iterative deconvolution. Subsequently, the SPM analysis was repeated using these partial volume corrected parametric images. Supplementary Fig 2 illustrates the impact of PVC on observed SPM differences. After PVC, clusters with significant differences became even smaller. It should be noted that it is likely that increased noise levels associated with PVC are responsible for these smaller clusters, and not atrophy in the AD group. Irrespective of the results, however, it can be concluded that comparisons at the voxel level are possible using parametric (BPND) images of 18F-DPA-714. To fully assess the impact of partial volume effects, further studies with a larger number of subjects are necessary.
A limitation of the present study was the lack of TSPO genotype information of the subjects. Unfortunately, it will not be possible to obtain these posthoc due to the sponsor's and ethical review board's rules and regulations. Furthermore, currently the binding affinity of 18F-DPA-714 to high-affinity binding and low-affinity binding sites is unknown (30) . Clearly, further studies are required in which subjects are selected for the same TSPO genotype. Another limitation might be the use of cerebellum as reference region, as increased binding in the reference region might result in an underestimation of BP ND (31) . Nevertheless, in many TSPO PET tracer studies cerebellum has been used as a reference tissue.
CONCLUSION
Logan and SA are both suitable plasma input based methods for generating quantitatively accurate parametric V T images. In case of reference tissue approaches, RLogan or SRTM2 can be used for generating parametric BP ND images. 
